CN102451462A - Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny - Google Patents

Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny Download PDF

Info

Publication number
CN102451462A
CN102451462A CN2010105370897A CN201010537089A CN102451462A CN 102451462 A CN102451462 A CN 102451462A CN 2010105370897 A CN2010105370897 A CN 2010105370897A CN 201010537089 A CN201010537089 A CN 201010537089A CN 102451462 A CN102451462 A CN 102451462A
Authority
CN
China
Prior art keywords
parts
tcm
chinese medicine
treating hyperosteogeny
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105370897A
Other languages
Chinese (zh)
Inventor
贺琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105370897A priority Critical patent/CN102451462A/en
Publication of CN102451462A publication Critical patent/CN102451462A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny. The TCM is characterized in that the TCM is prepared from the following components in parts by weight: 100 parts of moxa salt, 50-60 parts of cortex eucommiae, 50-60 parts of radix achyranthis bidentatae, 20-30 parts of dry ginger, 20-30 parts of papaya, 20-30 parts of liquorice, 20-30 parts of centipede, 20-30 parts of radix clematidis, 20-30 parts of aromatherapy essential oil and the balance of herba lysimachiae and moxa sticks. The TCM has the advantages of good effect on treating hyperosteogeny, low cost and no toxic or side effect.

Description

A kind of AIYAN Chinese medicine of treating hyperosteogeny
Technical field
The present invention relates to the field of Chinese medicines.Relate in particular to a kind of Chinese medicine of treating hyperosteogeny.
Background technology
The medicine of present known treatment hyperosteogeny is many, but the treatment effect that has is good inadequately, and the cost that has is high.
Summary of the invention
The object of the invention is exactly many to the medicine of present known treatment hyperosteogeny, but the treatment effect that has is good inadequately, the deficiency of the cost height that has, and a kind of smelting treatment hyperosteogeny that provides is effective, the Chinese medicine that cost is low.
A kind of AIYAN Chinese medicine of treating hyperosteogeny is characterized in that it is made up of AIYAN, Herba Lysimachiae, aromatic essential oil, Scolopendra, moxa roll and dried Rhizoma Zingiberis Recens, and its weight portion proportioning is:
AIYAN 100 Cortex Eucommiae 50-60 Radix Achyranthis Bidentatae 50-60
Dried Rhizoma Zingiberis Recens 20-30 Fructus Chaenomelis 20-30 Radix Glycyrrhizae 20-30
Scolopendra 20-30 Radix Clematidis 20-30 aromatic essential oil 20-30.
Advantage of the present invention is: it is effective that it treats hyperosteogeny to smelting, and cost is low, has no side effect.
The specific embodiment
Get AIYAN 100g, Cortex Eucommiae 50g, Radix Achyranthis Bidentatae 50g, dried Rhizoma Zingiberis Recens 20g, Fructus Chaenomelis 30g, Radix Glycyrrhizae 20g, Scolopendra 20g, Radix Clematidis 20g and be ground into powder, add aromatic essential oil 20g and mix well and get final product.This medicinal cloth collation package is processed warm moxibustion bag, during use warm moxibustion bag is heated to 50-60 ℃ of taking-up, the warm moxibustion bag after the heating was directly spread on affected part 20-30 minute, get final product.
Get AIYAN 100g, Cortex Eucommiae 60g, Radix Achyranthis Bidentatae 60g, dried Rhizoma Zingiberis Recens 30g, Fructus Chaenomelis 30g, Radix Glycyrrhizae 20g, Scolopendra 30g, Radix Clematidis 30g and be ground into powder, add aromatic essential oil 20g and mix well and get final product.This medicinal cloth collation package is processed warm moxibustion bag, during use warm moxibustion bag is heated to 50-60 ℃ of taking-up, the warm moxibustion bag after the heating was directly spread on affected part 20-30 minute, get final product.

Claims (1)

1. AIYAN Chinese medicine of treating hyperosteogeny is characterized in that it is made up of AIYAN, Herba Lysimachiae, aromatic essential oil, Scolopendra, moxa roll and dried Rhizoma Zingiberis Recens, and its weight portion proportioning is:
AIYAN 100 Cortex Eucommiae 50-60 Radix Achyranthis Bidentatae 50-60
Dried Rhizoma Zingiberis Recens 20-30 Fructus Chaenomelis 20-30 Radix Glycyrrhizae 20-30
Scolopendra 20-30 Radix Clematidis 20-30 aromatic essential oil 20-30.
CN2010105370897A 2010-10-27 2010-10-27 Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny Pending CN102451462A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105370897A CN102451462A (en) 2010-10-27 2010-10-27 Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105370897A CN102451462A (en) 2010-10-27 2010-10-27 Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny

Publications (1)

Publication Number Publication Date
CN102451462A true CN102451462A (en) 2012-05-16

Family

ID=46035405

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105370897A Pending CN102451462A (en) 2010-10-27 2010-10-27 Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN102451462A (en)

Similar Documents

Publication Publication Date Title
CN101337061A (en) Blood circulation promoting pain preventing plaster
CN103784930A (en) Foot soaking composition
CN104013688A (en) Traditional Chinese medicine fever cooling patch
CN102451461A (en) Traditional Chinese medicine (TCM) for treating hyperosteogeny
CN105853591A (en) Cold-dispelling and moist-removing medicinal liquor
CN102451462A (en) Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny
CN101757320A (en) Decoction medicine for treating acute suppurative otitis media
CN105311553A (en) Carbuncle eliminating ointment
CN202179689U (en) Far-infrared temperature-sensing dysmenorrhea plaster
CN103417783A (en) TCM seaweed mask for treatment of facial steroid corticosteroid dependent dermatitis
CN103768156A (en) Cold treating medicine and preparation method
CN102038906A (en) Medicament for treating psoriasis
CN104352621A (en) Sunstroke preventing and treating foot bath powder
CN101926871A (en) Method for preparing medicament for treating cold asthma
CN103566017A (en) Preparation method of traditional Chinese medicine wine for eliminating dampness and warming meridian
CN202982360U (en) Thermal-therapy medicine bag
CN104138501A (en) Traditional Chinese medicine for treating parasitic orchitis
CN103721198A (en) Traditional Chinese medicine pill for treating flooding
CN104524533B (en) Recovery paste for osteonosus medicine
CN106692666A (en) Kidney-tonifying traditional Chinese medicine
CN103721200A (en) Traditional Chinese medicine pill for treating sterility
CN103721076A (en) Traditional Chinese medicine pill for treating wind strike with loss of speech and sluggish speech
CN103721209A (en) Traditional Chinese medicine prescription for treating leukorrhea diseases caused by exuberance of interior dampness-heat
CN104415139A (en) Beriberi treatment aerosol
CN102698197A (en) Tablets for sweating and clearing damp and interior heat

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120516